Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1476 of 6351
-
Can a daily pill stop leukemia relapse after transplant?
Disease control Recruiting nowThe purpose of the study is to see if a study drug called asciminib is safe and okay for people to take after they've had treatment for a type of blood cancer called Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ B-ALL). We're looking at two groups of adults:…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Massive study checks if PCV20 vaccine stops pneumonia in At-Risk adults
Vaccine OngoingThe purpose of this study is to learn how well PCV20 stops adults from getting community-acquired pneumonia. Pneumonia is an infection of the lungs that can be caused by germs like bacteria, virus, or fungi. This study uses existing healthcare information. No participants will be…
Sponsor: Pfizer • Aim: Vaccine
Last updated Aug 27, 2026 00:00 UTC
-
New study tests simple ways to prevent dangerous sodium drop after brain surgery
Prevention Recruiting nowThe investigators are conducting this study to investigate new preventive measures for patients with low sodium levels (hyponatremia), which can occur after surgery on the pituitary gland. This hyponatremia is often caused by the syndrome of inappropriate antidiuresis (SIAD). SIA…
Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New study tests Brain-Saving drugs for stroke patients
Disease control Not yet recruitingThis study conducted a comprehensive evaluation of commonly used neuroprotective agents in acute ischemic stroke, assessing their real-world value across six dimensions: safety, efficacy, cost-effectiveness, innovativeness, appropriateness, and accessibility. Employing a prospect…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New pill could replace steroids for painful muscle condition
Disease control Not yet recruitingThe study intends to explore the efficacy and safety of Ivarmacitinib in therapy for polymyalgia rheumatica through a multicenter, randomized, double-blind, placebo-controlled study, and to explore the effectiveness of Ivarmacitinib as an oral glucocorticoid-sparing alternative i…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New cocktail of drugs aims to tackle tough pancreatic cancer
Disease control Not yet recruitingThis study is a prospective, open-label, single-arm clinical trial evaluating the safety and efficacy of tunlametinib in combination with gemcitabine/albumin-bound paclitaxel and an EGFR monoclonal antibody as first-line therapy in treatment-naive subjects with advanced pancreati…
Phase 4 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New weekly shot shows promise for diabetes and weight loss
Disease control Recruiting nowThis is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mellitus subjects who are obese or overweight with weight-related comorbidities. Subjects will be put on either one of the four treatm…
Phase 2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New triple therapy aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis open-label, single-arm study is designed to evaluate the safety and preliminary efficacy of NK010 cell injection combined with a PD-1 antibody and platinum-based chemotherapy as neoadjuvant therapy in patients with resectable non-small cell lung cancer (NSCLC). The study aim…
Phase 1 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New vaccine aims to shield infants from pneumonia
Prevention Recruiting nowThis is a phase 3 randomized, modified double-blind study whose purpose is to measure whether 3 lots of the investigational pneumococcal vaccine PCV21 can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) in a similar way (ie, same immune response…
Phase 3 • Sponsor: Sanofi • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
New study tests gentler way to give lung medicine to preterm infants
Disease control Recruiting nowRespiratory distress syndrome (RDS) is a common cause of respiratory failure in preterm infants and is frequently treated with surfactant therapy. With the increasing use of noninvasive ventilation, less invasive methods of surfactant administration have been developed. In the te…
Phase 4 • Sponsor: Uludag University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a common diabetes drug shield heart transplant patients from kidney damage?
Disease control Recruiting nowHeart transplant (HTx) is an established therapy for advanced heart disease that restores quality of life and improves survival. However, due to preexisting comorbidities combined with the immunosuppressive therapies required after transplantation, HTx recipients remain at high r…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo aims to prevent transplant complications
Disease control Recruiting nowThe researchers are doing this study to compare 2 different GVHD prevention (prophylaxis) approaches. The researchers will see which approach is good or more effective at preventing chronic GVHD until 1 year after allogeneic hematopoietic stem cell transplantation (allo-HCT).
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a diabetes drug help heart defect patients lose weight?
Disease control Not yet recruitingSeveral drugs have been shown effective in the treatment of obesity, with concomitant favourable cardiovascular effects. Today, there are no studies on novel anti-obesity drugs in patients with adult congenital heart disease (ACHD). Therefore, the investigators aim to study the e…
Phase 4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Psoriasis drug combo aims to tackle skin and cholesterol in one shot
Disease control Not yet recruitingThe aim is to evaluate the safety and efficacy of vunakizumab combined with recaticimab versus vunakizumab combined with placebo in the treatment of plaque psoriasis with dyslipidemia.
Phase 4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental 'Off-the-Shelf' NK cells aim to fight childhood leukemia
Disease control Not yet recruitingThis is a single-arm, open-label, dose-escalation and expansion, prospective clinical trial conducted in patients with relapsed or refractory pediatric B-cell acute lymphoblastic leukemia to evaluate the safety and efficacy of JY509 universal NK cell injection.
Early phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Radioactive drug plus immunotherapy shows promise for tough lung cancer
Disease control Recruiting nowThis is a phase I study to evaluate the safety and preliminary efficacy of \[225Ac\]Ac-DOTATATE injection combined with tislelizumab in the maintenance treatment period for patients of extensive-stage small cell lung cancer (ES-SCLC) with somatostatin receptors (SSTR)+ as first-l…
Phase 1 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Jail-Based PTSD therapy could curb overdose deaths after release
Disease control By invitation onlyOpioid overdose is the leading cause of death among people recently released from incarceration. Recent evidence also shows a rise in stimulant use among justice-involved populations, as well as growing rates of concurrent opioid and stimulant use. Yet, while there is growing res…
Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can an extra drug flush out hidden HIV? new study seeks answers
Disease control Recruiting nowBackground: Antiretroviral viral therapy (ART) allows people with human immunodeficiency (HIV) to live long, healthy lives. But ART is not a cure. HIV can remain in the body, in infected cells called reservoirs. If a person stops taking ART, the HIV can rebound and reach high le…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Vibrating platform may improve balance and thinking in Parkinson's
Symptom relief OngoingThe aim of this study is to evaluate the effects of different frequencies of Whole Body Vibration (WBV) application on balance, gait, cognitive functions, and dual-task performance in patients with Parkinson's disease. Study Hypotheses: H0.1 - There is no effect of different fr…
Sponsor: Izmir Bakircay University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New hope for rare cancers: drug combo shows promise in early trial
Disease control Recruiting nowBackground: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. It can be hard to study treatments for these diseases. One combination of drugs-enfortumab vedotin (EV) and pembrolizumab-…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC